Legend Biotech CorporationLEGNNASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | 206.87% |
| Q2 2025 | 78.95% |
| Q1 2025 | -25.22% |
| Q4 2024 | -8.43% |
| Q3 2024 | -1436.84% |
| Q2 2024 | -154.65% |
| Q1 2024 | 109.05% |
| Q4 2023 | -54.54% |
| Q3 2023 | 37.51% |
| Q2 2023 | 26.04% |
| Q1 2023 | -150.57% |
| Q4 2022 | 22.38% |
| Q3 2022 | -5579.52% |
| Q2 2022 | 98.57% |
| Q1 2022 | -24.91% |
| Q4 2021 | -27.08% |
| Q3 2021 | 33.84% |
| Q2 2021 | -104.92% |
| Q1 2021 | 38.30% |
| Q4 2020 | 4.31% |
| Q3 2020 | -5.53% |
| Q2 2020 | -10.70% |
| Q1 2020 | 37.97% |
| Q4 2019 | -594.43% |
| Q3 2019 | 151.45% |
| Q2 2019 | -63.67% |
| Q1 2019 | 0.00% |